Paper34869352
Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma.
Zhou F and 1 other. Front Cell Dev Biol, 2021. Cited by 61 papers, by iCite.
Cite this record
ConductScience Library. Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma. Papers, record 34869352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34869352
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R00 HL148504 | NHLBI NIH HHS | United States | R00HL148504 | PubMed |
Source NIH RePORTER
References94
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31567625 | Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Case-control Study. | J Clin Gastroenterol | 2020 | https://conductscience.org/library/papers/31567625 | PubMed |
| 2 | 31857717 | Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma. | Br J Cancer | 2020 | https://conductscience.org/library/papers/31857717 | PubMed |
| 3 | 29936596 | Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. | Cell Mol Life Sci | 2018 | https://conductscience.org/library/papers/29936596 | PubMed |
| 4 | 31761566 | Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis. | Cell Metab | 2020 | https://conductscience.org/library/papers/31761566 | PubMed |
| 5 | 33166677 | Cholesterol metabolism: At the cross road between cancer cells and immune environment. | Int J Biochem Cell Biol | 2020 | https://conductscience.org/library/papers/33166677 | PubMed |
| 6 | 28444290 | Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. | Eur Heart J | 2017 | https://conductscience.org/library/papers/28444290 | PubMed |
| 7 | 24425422 | Opposite association between diabetes, dyslipidemia, and hepatocellular carcinoma mortality in the middle-aged and elderly. | Hepatology | 2014 | https://conductscience.org/library/papers/24425422 | PubMed |
| 8 | 30454647 | Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. | Cell | 2018 | https://conductscience.org/library/papers/30454647 | PubMed |
| 9 | 32362324 | Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis. | Immunity | 2020 | https://conductscience.org/library/papers/32362324 | PubMed |
| 10 | 20658156 | Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. | J Gastroenterol | 2011 | https://conductscience.org/library/papers/20658156 | PubMed |
| 11 | 23813842 | NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. | Hepatology | 2014 | https://conductscience.org/library/papers/23813842 | PubMed |
| 12 | 18216769 | Cellular cholesterol trafficking and compartmentalization. | Nat Rev Mol Cell Biol | 2008 | https://conductscience.org/library/papers/18216769 | PubMed |
| 13 | 31112291 | Statin use and risk of liver cancer: Evidence from two population-based studies. | Int J Cancer | 2020 | https://conductscience.org/library/papers/31112291 | PubMed |
| 14 | 30912095 | Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms. | Semin Liver Dis | 2019 | https://conductscience.org/library/papers/30912095 | PubMed |
| 15 | 25220842 | Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. | Int J Cancer | 2015 | https://conductscience.org/library/papers/25220842 | PubMed |
| 16 | 24449766 | The E3 ubiquitin ligase MARCH6 degrades squalene monooxygenase and affects 3-hydroxy-3-methyl-glutaryl coenzyme A reductase and the cholesterol synthesis pathway. | Mol Cell Biol | 2014 | https://conductscience.org/library/papers/24449766 | PubMed |
| 17 | 26055276 | The Role of Dietary Cholesterol in Lipoprotein Metabolism and Related Metabolic Abnormalities: A Mini-review. | Crit Rev Food Sci Nutr | 2016 | https://conductscience.org/library/papers/26055276 | PubMed |
| 18 | 22761969 | Regulation and deregulation of cholesterol homeostasis: The liver as a metabolic "power station". | World J Hepatol | 2012 | https://conductscience.org/library/papers/22761969 | PubMed |
| 19 | 30520543 | Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high-fat diet. | Cancer Sci | 2019 | https://conductscience.org/library/papers/30520543 | PubMed |
| 20 | 29746928 | Cholesterol inhibits hepatocellular carcinoma invasion and metastasis by promoting CD44 localization in lipid rafts. | Cancer Lett | 2018 | https://conductscience.org/library/papers/29746928 | PubMed |
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42835162 | Mechanism of BaP- regulated hepatic lipid metabolism via AhR activation and AR modulation. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42835162 | PubMed |
| 42511559 | Clinical and Genetic Determinants of Hepatocellular Carcinoma in a Turkish Cohort: Impact of SLCO1B1 and SLCO1B3 Germline Variations and Demographic Risk Factors. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511559 | PubMed |
| 42374019 | Nur77 agonism invigorates Natural Killer cell immunity against hepatocellular carcinoma. | Nat Commun | 2026 | https://conductscience.org/library/papers/42374019 | PubMed |
| 42196975 | Melatonin and Selected Phytochemicals: A Promising Combination to Target Altered Metabolism in Cancer. | Nutrients | 2026 | https://conductscience.org/library/papers/42196975 | PubMed |
| 42144470 | Research status and challenges of anti-tumor effects of natural saponins and their combination therapy. | J Egypt Natl Canc Inst | 2026 | https://conductscience.org/library/papers/42144470 | PubMed |
| 42111169 | Cholesterol metabolism dysregulated by key HBV mutations revealed through multi-omics profiling. | iScience | 2026 | https://conductscience.org/library/papers/42111169 | PubMed |
| 42059033 | FDFT1 Acts as a Negative Regulator of Autophagy by Modulating AMPK-ULK1 Signaling in Hepatocellular Carcinoma Cells. | Biomol Ther (Seoul) | 2026 | https://conductscience.org/library/papers/42059033 | PubMed |
| 42033362 | Roles of FXR in Lipid Biochemistry within Hepatocellular Carcinoma Using MALDI MSI. | J Am Soc Mass Spectrom | 2026 | https://conductscience.org/library/papers/42033362 | PubMed |
| 42003876 | Development and Validation of Predictive Machine Learning Models for Postoperative Recurrence and Microvascular Invasion in Hepatocellular Carcinoma Using Nuclear Magnetic Resonance Metabolomics. | J Hepatocell Carcinoma | 2026 | https://conductscience.org/library/papers/42003876 | PubMed |
| 41994008 | Revisiting cholesterol metabolism in hepatocellular carcinoma: a hidden driver of systemic therapy response. | ESMO Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/41994008 | PubMed |
| 41965662 | Association of LDLR and SCARB1 gene polymorphisms with hepatocellular carcinoma: a case-control study proposing a 'double-hit' model. | Lipids Health Dis | 2026 | https://conductscience.org/library/papers/41965662 | PubMed |
| 41948649 | Interaction Patterns Among Risk Factors for Liver Cancer in Patients With Type 2 Diabetes in Primary Care: A Retrospective Cohort Study. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/41948649 | PubMed |
| 41673369 | HBV reprograms the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic implications. | Clin Exp Med | 2026 | https://conductscience.org/library/papers/41673369 | PubMed |
| 41375834 | Liver Fibrosis as a Predictor of Cardiovascular Risk in Patients with Severe Obesity. | J Clin Med | 2025 | https://conductscience.org/library/papers/41375834 | PubMed |
| 41350297 | Bidirectional crosstalk between ER stress and lipid metabolism: From proteostasis to tumor adaptation. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/41350297 | PubMed |
| 41271824 | Atorvastatin negatively regulates MAPK pathway in vitro to inhibit proliferation, migration, and invasion of hepatocellular carcinoma cells. | Sci Rep | 2025 | https://conductscience.org/library/papers/41271824 | PubMed |
| 41201177 | Recent Advancements in Known and Emerging Risk Factors of Hepatocellular Carcinoma. | Cancer Med | 2025 | https://conductscience.org/library/papers/41201177 | PubMed |
| 41179299 | Novel Strategies against Hepatocellular Carcinoma through Lipid Metabolism. | Oncol Res | 2025 | https://conductscience.org/library/papers/41179299 | PubMed |
| 41144600 | Comparison of Risk Factors, Their Interaction Patterns, and Scoring Systems for Liver Cancer Between Patients With and Those Without Diabetes: Retrospective Cohort Study Using Electronic Health Records and Tree-Structured Algorithms. | JMIR Med Inform | 2025 | https://conductscience.org/library/papers/41144600 | PubMed |
| 41098086 | The role of lipid metabolic interactions in reshaping the tumor microenvironment. | Acta Biochim Biophys Sin (Shanghai) | 2025 | https://conductscience.org/library/papers/41098086 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34869352
GET https://conductscience.org/api/papers/v1/34869352/references?page=2